Petros Pharmaceuticals宣布公开募股定价960万美元

2025-02-18 22:34

Petros Pharmaceuticals (NASDAQ:PTPI) on Tuesday announced the pricing of a public offering of approximately 40 million shares of the company's common stock.
The company said each share of common stock accompanied by a Series A warrant to purchase 0.25 share of common stock at $0.48 per 0.25 share and a Series B Warrant to purchase one share of common stock at $0.48 per share.
The combined public offering price of each share of common stock together with the accompanying Series A warrant and Series B warrant is $0.24, and the combined public offering price of each pre-funded warrant together with the accompanying Series A Warrant and Series B Warrant is $0.2399, it added.
The closing of the public offering is expected to occur on or about February 19, 2025.
The gross proceeds of the public offering are expected to be approximately $9.6 million. The company intends to use the net proceeds from the offering for working capital and general corporate purposes.
PTPI -35.87% premarket to $0.1879.
Source: Press Release

More on Petros Pharmaceuticals